AC
ESPR

Amia Capital’s Esperion Therapeutics ESPR Stock Holding History

Amia Capital’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,464
Closed -$761K – 13
2020
Q3 		$761K Sell
20,464
-439
-2% -$17.4K 0.88% 18
2020
Q2 		$1.07M Sell
20,903
-11,589
-36% -$485K 0.88% 16
2020
Q1 		$1.02M Sell
32,492
-8,071
-20% -$426K 0.91% 18
2019
Q4 		$2.42M Buy
+40,563
New +$1.82M 0.71% 15

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Amia Capital's ESPR Position: Q4 2020 in Review

Amia Capital sold out of Esperion Therapeutics (ESPR) in Q4 2020, closing a stake of 20,464 shares — an estimated $761K sold.

Amia Capital first reported a position in ESPR in Q4 2019 and held it in 4 quarters. The position peaked at $2.42M in Q4 2019. 157 funds tracked by Wall St. Rank hold ESPR as of Q4 2020.

  • Amia Capital reported no remaining Esperion Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 20,464 Esperion Therapeutics shares in Q4 2020, an estimated $761K.
  • Amia Capital first reported a position in Esperion Therapeutics in Q4 2019 and held it in 4 quarters.
  • Amia Capital's Esperion Therapeutics position peaked at $2.42M in Q4 2019.
  • 157 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.